Stable translocations detected by fluorescence in situ hybridization : A rapid surrogate end point to evaluate the efficacy of a potentiator of tumor response to radiotherapy

Testing potential modifiers of the response of tumors to radiation therapy requires large, expensive, and time-consuming clinical trials. It would, therefore, be of value to have a rapid surrogate end point of tumor response that could be used to evaluate such modifiers. We here propose that radiati...

Ausführliche Beschreibung